SCHEMBL17126862

SCHEMBL17126862

CCOCCSC(C(=O)c1ccc(Oc2ccc3cc(OC)ccc3c2)cc1)C(C)(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AKR1C3 P42330 5/20 0.39
▸ AKR1C2 P52895 5/20 0.39
▸ PTGS1 P23219 2/20 0.39
▸ AKR1C1 Q04828 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ HPGD P15428 2/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ MTNR1A P48039 1/20 0.37
▸ MTNR1B P49286 1/20 0.37
▸ SLC2A1 P11166 1/20 0.35
▸ SCN9A Q15858 1/20 0.35
▸ LMNA P02545 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ GABBR2 O75899 1/20 0.34
▸ GABBR1 Q9UBS5 1/20 0.34
▸ PARP10 Q53GL7 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17126864 0.93 SCN9A (0.33) AKR1C3AKR1C2PTGS1AKR1C1KDM4E
SCHEMBL17126973 0.92 SMN1; SMN2 (0.43) KDM4EHPGDSMN1; SMN2ALDH1A1CYP1A2
SCHEMBL17127022 0.92 PTGS2 (0.38) KDM4ESMN1; SMN2ALDH1A1SCN9ALMNA
SCHEMBL17126863 0.90 ACACB (0.37) SMN1; SMN2SLC2A1LMNA
SCHEMBL15935680 0.89 SMN1; SMN2 (0.46) KDM4EHPGDSMN1; SMN2ALDH1A1CYP1A2
SCHEMBL17126975 0.88 TTR (0.39) HPGDSMN1; SMN2ALDH1A1LMNAHTT
SCHEMBL17126856 0.87 SMN1; SMN2 (0.33) SMN1; SMN2MTNR1AMTNR1BSLC2A1SCN9A
SCHEMBL17127350 0.87 HIF1A (0.39) AKR1C3AKR1C2PTGS1AKR1C1SMN1; SMN2
SCHEMBL17126976 0.85 PPARA (0.40) HPGDSMN1; SMN2ALDH1A1PARP10
SCHEMBL17127019 0.85 LMNA (0.41) KDM4EHPGDSMN1; SMN2ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150277225-A1 ACTINIC-RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM FORMED USING SAID COMPOSITION, METHOD FOR FORMING PATTERN USING SAID COMPOSITION, PROCESS FOR PRODUCING ELECTRONIC DEVICE, AND ELECTRONIC DEVICE FUJIFILM CORPORATION (JP) 2015-10-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150277225-A1 ACTINIC-RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM FORMED USING SAID COMPOSITION, METHOD FOR FORMING PATTERN USING SAID COMPOSITION, PROCESS FOR PRODUCING ELECTRONIC DEVICE, AND ELECTRONIC DEVICE TERB1, ACTR5, ADPRS AKR1C3 3314/4885AKR1C2 2465/4885PTGS1 2652/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback